Business Description
DXS International PLC
NAICS : 518210
SIC : 7374
ISIN : GB00B2Q6HZ92
Description
DXS International PLC is engaged in the development and distribution of clinical decision support, content, and technology to general practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its products include CompleteCare, ExpertCare, and MyVytalCare.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.34 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | 1.65 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.07 | |||||
| Beneish M-Score | -2.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1 | |||||
| 3-Year EBITDA Growth Rate | -8 | |||||
| 3-Year EPS without NRI Growth Rate | -23.1 | |||||
| 3-Year Book Growth Rate | 7.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -50.91 | |||||
| 12-1 Month Momentum % | -68.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.34 | |||||
| Quick Ratio | 1.34 | |||||
| Cash Ratio | 0.43 | |||||
| Days Sales Outstanding | 40.15 | |||||
| Days Payable | 104.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -63.66 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 86.23 | |||||
| Operating Margin % | -1.27 | |||||
| Net Margin % | 6.64 | |||||
| FCF Margin % | -16.57 | |||||
| ROE % | 5.03 | |||||
| ROA % | 3.37 | |||||
| ROIC % | 1.62 | |||||
| ROC (Joel Greenblatt) % | -23.18 | |||||
| ROCE % | -0.74 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 2.7 | |||||
| PE Ratio without NRI | 2.7 | |||||
| PEG Ratio | 0.37 | |||||
| PS Ratio | 0.19 | |||||
| PB Ratio | 0.14 | |||||
| Price-to-Operating-Cash-Flow | 0.79 | |||||
| EV-to-EBIT | -36.88 | |||||
| EV-to-Forward-EBIT | -36.24 | |||||
| EV-to-EBITDA | 2.39 | |||||
| EV-to-Revenue | 0.47 | |||||
| EV-to-Forward-Revenue | 0.54 | |||||
| EV-to-FCF | -2.82 | |||||
| Price-to-Projected-FCF | 0.45 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.34 | |||||
| Earnings Yield (Greenblatt) % | -2.71 | |||||
| FCF Yield % | -65.05 | |||||
| Forward Rate of Return (Yacktman) % | -39.62 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers